Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Interest & Investment Income for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 46.62% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 million, a 11.4% increase, with the full-year FY2025 number at $6.0 million, up 11.4% from a year prior.
  • Interest & Investment Income was $1.2 million for Q4 2025 at Artiva Biotherapeutics, down from $1.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.2 million in Q4 2024 to a low of $418000.0 in Q3 2023.
  • A 3-year average of $1.2 million and a median of $1.3 million in 2025 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: soared 341.63% in 2024, then tumbled 46.62% in 2025.
  • Artiva Biotherapeutics' Interest & Investment Income stood at $584000.0 in 2023, then soared by 272.77% to $2.2 million in 2024, then crashed by 46.62% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for ARTV's Interest & Investment Income are $1.2 million (Q4 2025), $1.4 million (Q3 2025), and $1.6 million (Q2 2025).